Agilent Technologies, Inc.
Agilent Technologies posted solid first-quarter results for fiscal 2026, with revenues of $1.8 billion, reflecting a 4.4% core growth despite weather-related disruptions, while operating margins held steady at 24.6%.
Key takeaways
- Revenue growth was slightly impacted by a $10 million loss from a U.S. winter storm but was otherwise within November guidance range.
- Operating margins remained stable at 24.6%, with expectations for sequential improvement driven by increasing volumes and decreasing tariff headwinds.
- EPS for the quarter was reported at $1.36, with adjusted figures suggesting stronger performance above guidance midpoints.
- Agilent's enterprise services business continues to grow rapidly, marking a low double-digit CAGR and enhancing customer relationships with major biopharma accounts.
- New product introductions, particularly the Altura column portfolio and Pro iQ LC/MS, have shown strong market reception, indicating robust demand and competitive advantage in the biopharma space.